Propiverine-induced accumulation of nuclear and cytosolic protein in F344 rat kidneys: isolation and identification of the accumulating protein.
Male and female F344 rats but not B6C3F1 mice exposed for 104 weeks to propiverine hydrochloride (1-methylpiperid-4-yl 2,2-diphenyl-2-(1-propoxy)acetate hydrochloride), used for treatment of patients with neurogenic detrusor overactivity (NDO) and overactive bladder (OAB), presented with an accumulation of proteins in the cytosol and nuclei of renal proximal tubule epithelial cells, yet despite this, no increased renal tumor incidence was observed. In order to provide an improved interpretation of these findings and a better basis for human health risk assessment, male and female F344 rats were exposed for 16 weeks to 1000 ppm propiverine in the diet, the accumulating protein was isolated from the kidneys via cytosolic and nuclear preparations or laser-capture microdissection and analyzed using molecular weight determination and mass spectrometry. The accumulating protein was found to be d-amino acid oxidase (DAAO), an enzyme involved in amino and fatty acid metabolism. Subsequent reanalysis of kidney homogenate and nuclear samples as well as tissue sections using western blot and DAAO-immunohistochemistry, confirmed the presence and localization of DAAO in propiverine-treated male and female F344 rats. The accumulation of DAAO only in rats, and the limited similarity of rat DAAO with other species, including humans, suggests a rat-specific mechanism underlying the drug-induced renal DAAO accumulation with little relevance for patients chronically treated with propiverine.
Dietrich
D R
DR
Environmental Toxicology, University of Konstanz, 78457 Konstanz, Germany. daniel.dietrich@uni-konstanz.de
Heussner
A H
AH
O'Brien
E
E
Gramatté
T
T
Runkel
M
M
Rumpf
S
S
Day
B W
BW
D000595:Amino Acid Sequence; D000818:Animals; D001561:Benzilates / Q000009:adverse effects* / Q000493:pharmacokinetics; D002467:Cell Nucleus / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D018680:Cholinergic Antagonists / Q000009:adverse effects* / Q000493:pharmacokinetics; D003600:Cytosol / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D003605:D-Amino-Acid Oxidase / Q000302:isolation & purification / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006818:Hyalin / Q000378:metabolism; D007150:Immunohistochemistry; D007668:Kidney / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008969:Molecular Sequence Data; D011487:Protein Conformation; D051381:Rats; D011916:Rats, Inbred F344; D012737:Sex Factors
D001561:Benzilates; D018680:Cholinergic Antagonists; C015586:propiverine; D003605:D-Amino-Acid Oxidase